291 related articles for article (PubMed ID: 23875672)
1. 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.
Rischke HC; Nestle U; Fechter T; Doll C; Volegova-Neher N; Henne K; Scholber J; Knippen S; Kirste S; Grosu AL; Jilg CA
Radiat Oncol; 2013 Jul; 8():183. PubMed ID: 23875672
[TBL] [Abstract][Full Text] [Related]
2. Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.
Harvey H; Orton MR; Morgan VA; Parker C; Dearnaley D; Fisher C; deSouza NM
Br J Radiol; 2017 Mar; 90(1071):20160416. PubMed ID: 28055249
[TBL] [Abstract][Full Text] [Related]
3. Gross tumour volume delineation in anal cancer on T2-weighted and diffusion-weighted MRI - Reproducibility between radiologists and radiation oncologists and impact of reader experience level and DWI image quality.
Min LA; Vacher YJL; Dewit L; Donker M; Sofia C; van Triest B; Bos P; van Griethuysen JJW; Maas M; Beets-Tan RGH; Lambregts DMJ
Radiother Oncol; 2020 Sep; 150():81-88. PubMed ID: 32540336
[TBL] [Abstract][Full Text] [Related]
4. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer GTV delineation with biparametric MRI and
Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
Han K; Croke J; Foltz W; Metser U; Xie J; Shek T; Driscoll B; Ménard C; Vines D; Coolens C; Simeonov A; Beiki-Ardakani A; Leung E; Levin W; Fyles A; Milosevic MF
Radiother Oncol; 2016 Sep; 120(3):519-525. PubMed ID: 27528120
[TBL] [Abstract][Full Text] [Related]
7. Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: Implications for radiotherapy planning.
Regini F; Gourtsoyianni S; Cardoso De Melo R; Charles-Edwards GD; Griffin N; Parikh J; Rottenberg G; Leslie M; Gaya A; Goh V
Eur J Radiol; 2014 May; 83(5):768-72. PubMed ID: 24646719
[TBL] [Abstract][Full Text] [Related]
8. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
9. Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer.
Burbach JP; Kleijnen JP; Reerink O; Seravalli E; Philippens ME; Schakel T; van Asselen B; Raaymakers BW; van Vulpen M; Intven M
Radiother Oncol; 2016 Feb; 118(2):399-407. PubMed ID: 26700601
[TBL] [Abstract][Full Text] [Related]
10. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers.
Caravatta L; Cellini F; Simoni N; Rosa C; Niespolo RM; Lupattelli M; Picardi V; Macchia G; Sainato A; Mantello G; Dionisi F; Rosetto ME; Fusco V; Navarria F; De Paoli A; Guido A; Vecchi C; Basilico R; Cianci R; Delli Pizzi A; Di Nicola M; Mattiucci GC; Valentini V; Morganti AG; Genovesi D
Acta Oncol; 2019 Apr; 58(4):439-447. PubMed ID: 30632876
[TBL] [Abstract][Full Text] [Related]
12. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
13. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
Sathiadoss P; Schieda N; Haroon M; Osman H; Alrasheed S; Flood TA; Melkus G
J Magn Reson Imaging; 2022 Jan; 55(1):265-274. PubMed ID: 34223675
[TBL] [Abstract][Full Text] [Related]
14. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
[TBL] [Abstract][Full Text] [Related]
15. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy.
Pathmanathan AU; McNair HA; Schmidt MA; Brand DH; Delacroix L; Eccles CL; Gordon A; Herbert T; van As NJ; Huddart RA; Tree AC
Br J Radiol; 2019 Mar; 92(1095):20180948. PubMed ID: 30676772
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
[TBL] [Abstract][Full Text] [Related]
18. Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences.
Lucas R; Lopes Dias J; Cunha TM
Diagn Interv Radiol; 2015; 21(5):368-75. PubMed ID: 26200480
[TBL] [Abstract][Full Text] [Related]
19. Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.
Nguyen HT; Pohar KS; Jia G; Shah ZK; Mortazavi A; Zynger DL; Wei L; Clark D; Yang X; Knopp MV
Invest Radiol; 2014 Jun; 49(6):390-5. PubMed ID: 24637583
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
Benndorf M; Hahn F; Krönig M; Jilg CA; Krauss T; Langer M; Dovi-Akué P
Eur J Radiol; 2017 Aug; 93():9-15. PubMed ID: 28668436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
